Device
Dynasplint
Total Trials
4
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Completion Rate
0%(0/3)
Active Trials
0(0%)
Terminated
3(75%)
Phase Distribution
Ph not_applicable
4
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
0.0%
0 of 4 finished
Non-Completion Rate
100.0%
4 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Terminated(4)
Detailed Status
Terminated3
Withdrawn1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
0.0%
Most Advanced
N/A
Trials by Phase
N/A4 (100.0%)
Trials by Status
withdrawn125%
terminated375%
Recent Activity
0 active trials
Showing 4 of 4
terminatednot_applicable
Dynamic Splinting for Patients With Adhesive Capsulitis
NCT00873158
terminatednot_applicable
Adhesive Capsulitis and Dynamic Splinting
NCT01874821
terminatednot_applicable
Ankle Equinus Contracture Treated With Dynamic Splinting
NCT01238484
withdrawnnot_applicable
Dynamic Splinting for Excessive Pronation Following CVA
NCT00900692
Clinical Trials (4)
Showing 4 of 4 trials
NCT00873158Not Applicable
Dynamic Splinting for Patients With Adhesive Capsulitis
NCT01874821Not Applicable
Adhesive Capsulitis and Dynamic Splinting
NCT01238484Not Applicable
Ankle Equinus Contracture Treated With Dynamic Splinting
NCT00900692Not Applicable
Dynamic Splinting for Excessive Pronation Following CVA
All 4 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 4